(1R,3S)-N-(biphenyl-4-yl)-3-(6-(dimethylamino)hexanamido)-N-methylcyclopentanecarboxamide

ID: ALA1834180

Chembl Id: CHEMBL1834180

PubChem CID: 56682065

Max Phase: Preclinical

Molecular Formula: C27H37N3O2

Molecular Weight: 435.61

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)CCCCCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3ccccc3)cc2)C1

Standard InChI:  InChI=1S/C27H37N3O2/c1-29(2)19-9-5-8-12-26(31)28-24-16-13-23(20-24)27(32)30(3)25-17-14-22(15-18-25)21-10-6-4-7-11-21/h4,6-7,10-11,14-15,17-18,23-24H,5,8-9,12-13,16,19-20H2,1-3H3,(H,28,31)/t23-,24+/m1/s1

Standard InChI Key:  NZVLYMJHQXCHFY-RPWUZVMVSA-N

Associated Targets(Human)

FASN Tchem Fatty acid synthase (3390 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 435.61Molecular Weight (Monoisotopic): 435.2886AlogP: 4.72#Rotatable Bonds: 10
Polar Surface Area: 52.65Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.79CX LogP: 4.02CX LogD: 1.66
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.55Np Likeness Score: -0.96

References

1. Kley JT, Mack J, Hamilton B, Scheuerer S, Redemann N..  (2011)  Discovery of BI 99179, a potent and selective inhibitor of type I fatty acid synthase with central exposure.,  21  (19): [PMID:21873051] [10.1016/j.bmcl.2011.07.083]
2.  (2017)  Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use,